⌘K

Login Start Free

Home/Filings/4/0001213900-18-004250

4//SEC Filing

Hexter Joshua 4

Accession 0001213900-18-004250

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 5:41 PM ET

Size

5.4 KB

Accession

0001213900-18-004250

Insider Transaction Report

Form 4

Period: 2018-04-08

ORAMED PHARMACEUTICALS INC.ORMP

COO & CBO

Transactions

Award
Stock option (right to buy)
2018-04-08+30,000→ 30,000 total
Exercise: $7.05Exp: 2028-04-08→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]The Stock Option will vest in 4 equal installments of 7,500 on each of April 1, 2019, April 1, 2020, April 1, 2021 and April 1, 2022.

Documents

1 file

4
f4040818hexter_oramedpharm.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001573235

Filing Metadata

Form type: 4
Filed: Apr 9, 8:00 PM ET
Accepted: Apr 10, 5:41 PM ET
Size: 5.4 KB

View on SEC.gov